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ABSTRACT
Binocular diplopia is a debilitating visual symptom
requiring immediate intervention for symptomatic control,
whether or not deﬁnitive treatment is eventually
possible. Where prismatic correction is infeasible, the
current standard is occlusion, either by a patch or an
opaque contact lens. In eliminating one problem—
diplopia—occlusive techniques invariably create another:
reduced peripheral vision. Crucially, this is often
unnecessary, for the reduced spatial resolution in the
periphery limits its contribution to the perception of
diplopia. Here, we therefore introduce a novel soft
contact lens device that instead creates a monocular
central scotoma inversely mirroring the physiological
variation in spatial acuity across the monocular visual
ﬁeld, thereby suppressing the diplopia with minimal
impact on the periphery. We compared the device
against standard eye patching in 12 normal subjects
with prism-induced binocular diplopia and 12 patients
with binocular diplopia of diverse causes. Indexed by
self-reported scores and binocular perimetry, the
scotogenic contact lens was comparably effective in
eliminating the diplopia while signiﬁcantly superior in
acceptability and its impact on the peripheral visual ﬁeld.
This simple, inexpensive, non-invasive device may thus
be an effective new tool in the treatment of a familiar
but still troublesome clinical problem.
INTRODUCTION
It is widely assumed that innovation in medical
treatment can only follow innovation in medical
science, novel action naturally requiring novel fact.
But there is a great deal of established fact—espe-
cially in physiology—whose therapeutic potential is
underappreciated.
Here we apply such ‘retro-innovation’ to the man-
agement of binocular diplopia, a symptom reported
by an estimated 120 000 people in the UK (data
from Driver and Vehicle Licensing Agency for
2010). Where the misalignment of the eyes cannot
be immediately corrected—the majority—the
common approach is to remove one of the two
images by occluding one eye, usually with a
‘pirate-style’ eye patch. This eliminates the
symptom, but at the cost of creating another: a
reduction in the visual ﬁeld between 48% and
76%.1 Crucially, while we do not use the peripheral
visual ﬁeld for exploratory vision, its sharp temporal
sensitivity is key to navigating in response to sudden
events.2 Many patients ﬁnd its loss unsettling, some-
times as much as the diplopia itself.3
The high temporal sensitivity of the peripheral
ﬁeld, however, is offset by low spatial sensitivity.4 5
Since diplopia is principally a percept in space, not
time, it typically does not occur in the periphery,
for the spatial detail of the perceived image is too
low there. The same is generally true of the rarer
symptom of confusion: the perception of two dif-
ferent overlapping objects owing to binocular mis-
alignment. To eliminate diplopia by occlusion, one
therefore does not have to obscure the whole ﬁeld
but only to degrade it in a pattern that is the
inverse of the variation in spatial acuity across the
visual ﬁeld: in short, one has to create a central
scotoma in one eye (ﬁgure 1A). The result, predict-
able from the well-known physiology of vision, is
abolition of diplopia with minimal impact on the
peripheral ﬁeld. Current occlusive contact lenses
and implantable lenses either abolish vision in the
eye altogether or degrade vision in a way that does
not target this theoretical optimum.6
Though seemingly complex, this effect is readily
achieved with the aid of a contact lens that simply
blurs the image in the corresponding pattern with
the aid of dispersant distributed in a radially redu-
cing concentration (ﬁgure 1B). Here, we report the
design and evaluation of a prototype of such a ‘sco-
togenic’ lens (coined from the Greek σκότος (dark-
ness)+γένεσις (creation)) in 12 normal participants
with artiﬁcially induced diplopia and 12 patients
with symptomatic diplopia of a disparate variety of
causes, compared against conventional eye patching.
METHODS
We created a prototype scotogenic lens by precipi-
tating barium sulfate within the substance of a soft
hydrolens contact lens in the form of a disc with
radially thinning edges of an approximate overall
diameter of 7 mm. Dye was added to the precipitate
so as to achieve the appearance of a black pupil. The
parameters of the lens were base curve 8.60 mm and
diameter 14 mm, a ﬁtting that suited all participants
in the study. The base lenses were manufactured by
Cantor and Nissel (http://www.cantor-nissel.co.uk/)
and the prototypes were prepared by SCL Contact
Lenses (http://www.sclcontactlenses.com/).
To evaluate the performance of the lens, we
recruited 12 healthy adult volunteers and 12 adult
patients with binocular diplopia attending the oph-
thalmology service at Imperial College Healthcare
National Health Service Trust. The former were
unselected except for freedom from any signiﬁcant
ophthalmological disease. The inclusion criterion
for the latter was the presence of symptomatic bin-
ocular diplopia of any cause; exclusion criteria were
inability to give informed consent, contraindications
to soft contact lens use and inability to complete a
questionnaire. The characteristics of the patients
are summarised in online supplementary table S1.
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In most cases, diplopia was secondary to an oculomotor palsy or
restriction, so that the deviation and impairment varied consider-
ably according to gaze position. All patients had previously been
comprehensively evaluated by an ophthalmologist (VF) and
found to be free from contraindications to soft contact lens use.
In addition, all participants were evaluated immediately before
the testing session by an optometrist (FB), including a clinical
assessment of visual acuity and motility and slit lamp examin-
ation of the ocular surface. Diplopia in the healthy participant
group was artiﬁcially induced with the aid of a Fresnel prism
applied to one eye, generating a 10° full-ﬁeld misalignment.
The evaluation process involved wearing either the scotogenic
lens or a black occlusive patch on one eye—each for a period of
30 min of free reading and room exploration, with the order
randomised across participants—followed by completion of a
questionnaire where effectiveness in abolishing the symptom,
comfort, aesthetics, and overall success were each rated on a
10-point scale (0 poor, 10 perfect, see online supplementary
material). In addition, automated Estermann perimetry was per-
formed on the normal participants in each test condition with a
Humphrey visual ﬁeld apparatus.
Questionnaire scores and the results from the Estermann per-
imetry were analysed by standard two sample Kolmogorov–
Smirnoff (K–S) tests, quoting asymptotic p values. We used K–S
because it makes no assumptions about the nature of the under-
lying distributions and is maximally conservative, minimising
the risk of type II errors.
RESULTS
In the normal participant group (table 1), both methods were
equally effective in abolishing binocular diplopia and in
comfort, but the lens was rated signiﬁcantly superior in aesthet-
ics and overall. Performance on Estermann perimetry was sig-
niﬁcantly superior with the lens, further illustrated in a heatmap
of the mean difference between the two conditions at each ﬁeld
location (ﬁgure 2).
In the patient group (table 2), both methods were identically
effective in abolishing binocular diplopia, but the lens was sig-
niﬁcantly superior to all other measures.
DISCUSSION
We show that it is possible to eliminate diplopia by selective
degradation of the image in one eye without signiﬁcantly
Table 1 Questionnaire and Estermann scores for the group of
normal participants with artificially induced diplopia
Test
Occlusive patch
(means)
Scotogenic lens
(means)
Significance
(K–S test),
p value
Symptom control 8.42 8.75 0.991
Comfort 6.50 6.17 0.990
Aesthetics 2.33 8.75 <0.001
Overall
assessment
6.42 8.67 0.005
Estermann score 14.92 missed locations 0.92 missed locations <0.001
Bold represents significance at the p=0.05 level.
K–S, Kolmogorov–Smirnoff.
Figure1 (A) Diagrammatic representation of the variation in spatial
acuity across the visual ﬁeld (black line) and the consequently optimal
pattern of degradation of the perceived image produced by a
scotogenic lens designed to abolish binocular diplopia with minimal
effect on the peripheral visual ﬁeld (white line). (B) Diagram of the
design of a scotogenic contact lens (not to scale). Dispersant material
(in our prototypes barium sulfate combined with black dye) is
introduced in the substance of the lens so as to produce the optimal
pattern of degradation of acuity across the visual ﬁeld described in (A).
Figure 2 Heatmap depicting the mean difference between the two
conditions for each location of the Estermann perimetry test. For each
participant, a location was given a 1 if successfully detected with the
lens but not the patch, and −1 if detected with the patch but not the
lens. Mean values close to 1 therefore indicate superiority of the lens
across the group (red to yellow range), and values close to −1 the
converse (blue to cyan range). Locations without a difference are given
in grey. Note that where there is a difference the lens is substantially
superior for all locations but one.
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impairing peripheral vision, thereby eliminating a major nega-
tive consequence of occlusion. The comparison with eye-patch
occlusion—the most effective means of eliminating diplopia
across the entire ﬁeld—maximised the stringency of the test.
Preserving peripheral vision beneﬁts all patients, but especially
those with pre-existing ﬁeld defects in whom full monocular
occlusion may disqualify from important activities such as
driving.
Though the extent of image degradation will interact with the
size of the pupil, we did not observe functionally signiﬁcant
consequences of such variation—perhaps because of the graded
boundary—despite considerable variability in pupil size. In any
event, the direction of variation is favourable to the effect we
are seeking, for a more pronounced effect is desirable where
illumination is higher and therefore acuity greater. The graded
boundary will also minimise the perception of contact lens
movement. Clinical embodiments of the device may allow a
choice of scotoma sizes, allowing tailoring for this and other
effects such as interindividual variability in Panum’s fusional
area.
Though here we use a dispersant material—following occlu-
sive lens technology—essentially identical perceptual effects can
be achieved by diffraction, without altering the substance of the
lens. Even so, the much smaller amount of dispersant material
used in our prototypes compared with fully occlusive lenses
greatly minimised any adverse impact on oxygen permeability.
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Table 2 Questionnaire scores for the group of patients with
diplopia
Test
Occlusive patch
(means)
Scotogenic lens
(means)
Significance
(K–S test), p value
Symptom control 9.73 9.27 0.985
Comfort 4.36 7.45 0.047
Aesthetics 2.00 9.45 <0.001
Overall
assessment
4.18 8.54 <0.001
K–S, Kolmogorov–Smirnoff.
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